WuXi Biologics (Cayman) Inc (WXXWY)
3.82
-0.19
(-4.74%)
USD |
OTCM |
Nov 14, 15:58
WuXi Biologics Enterprise Value: 7.772B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 7.772B |
| November 12, 2024 | 8.060B |
| November 11, 2024 | 8.183B |
| November 08, 2024 | 8.224B |
| November 07, 2024 | 8.840B |
| November 06, 2024 | 8.512B |
| November 05, 2024 | 8.573B |
| November 04, 2024 | 8.319B |
| November 01, 2024 | 8.049B |
| October 31, 2024 | 8.162B |
| October 30, 2024 | 8.121B |
| October 29, 2024 | 8.491B |
| October 28, 2024 | 8.738B |
| October 25, 2024 | 8.635B |
| October 24, 2024 | 8.090B |
| October 23, 2024 | 8.224B |
| October 22, 2024 | 8.203B |
| October 21, 2024 | 8.049B |
| October 18, 2024 | 8.224B |
| October 17, 2024 | 7.399B |
| October 16, 2024 | 7.710B |
| October 15, 2024 | 7.813B |
| October 14, 2024 | 8.571B |
| October 11, 2024 | 8.984B |
| October 10, 2024 | 8.994B |
| Date | Value |
|---|---|
| October 09, 2024 | 9.015B |
| October 08, 2024 | 9.498B |
| October 07, 2024 | 11.55B |
| October 04, 2024 | 10.73B |
| October 03, 2024 | 9.313B |
| October 02, 2024 | 10.06B |
| October 01, 2024 | 8.758B |
| September 30, 2024 | 8.470B |
| September 27, 2024 | 7.916B |
| September 26, 2024 | 6.930B |
| September 25, 2024 | 6.601B |
| September 24, 2024 | 6.562B |
| September 23, 2024 | 6.249B |
| September 20, 2024 | 6.463B |
| September 19, 2024 | 5.868B |
| September 18, 2024 | 5.500B |
| September 17, 2024 | 5.513B |
| September 16, 2024 | 5.479B |
| September 13, 2024 | 5.500B |
| September 12, 2024 | 5.561B |
| September 11, 2024 | 5.404B |
| September 10, 2024 | 5.164B |
| September 09, 2024 | 5.423B |
| September 06, 2024 | 5.137B |
| September 05, 2024 | 5.183B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.912B
Minimum
Aug 22 2024
88.18B
Maximum
Nov 20 2020
30.50B
Average
26.20B
Median
Apr 21 2023
Enterprise Value Benchmarks
| Zai Lab Ltd | 2.423B |
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Adagene Inc | 29.78M |
| LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | 4.37% |
| Operating Earnings Yield | 6.85% |
| Normalized Earnings Yield | 4.516 |